Skip to main content

Feedback on the documentary RARE

When I returned from Puerto Rico, I was very moved to find a little package of messages from secondary school science teachers who had been able to attend a screening of the documentary “RARE” at a recent teacher’s convention.


For new readers, the film “RARE” follows Donna Appell, her daughter Ashley, and myself through a three-year journey to fill a drug trial for a potential treatment for the pulmonary fibrosis of Hermansky-Pudlak Syndrome.


Donna also got a packet of these messages, but she got hers before we left on our trip.


I couldn’t help but be moved by the sweet messages of support. It encouraged me to hear how moved some people were by the film because that gives me even more hope that this film will be a breakthrough for awareness of HPS. Even more than that, we believe the film tells the story of rare diseases in general that face so many extra challenges to finding treatments, and someday, cures.


It feels a little funny, honestly, to have someone tell you you’re inspirational, or brave (as many of the messages did.) One never thinks of one’s self in such terms. I know so many HPS’ers that make my experience look so easy that it makes me uncomfortable to take in such compliments. After all, we don’t mean to be inspirational or brave – we weren’t exactly given much of a choice. We’re just doing what we have to do to survive, and hoping that the HPS’ers of the future will benefit from what we’ve done. How could anyone do any different?


Still, I’m happy for the compliments. I’m even happier that it seems the film made such a strong impression on the outsiders that have seen it.


I’ve now seen the film screened twice, but always to an HPS audience. It would be interesting to see the reactions of an audience for whom HPS, and those of us appearing in the film, are foreign.


Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for...

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria...